Mexico vs Singapore: Coverage of the human papillomavirus vaccine
Mexico
72
in 2025
Singapore
71
in 2025
Mexico rank
36th
Singapore rank
39th
Coverage of the human papillomavirus vaccine over time
- Mexico
- Singapore
How they compare
Mexico currently reports 72 against 71 in Singapore, a difference of 1.
The two have swapped places 2 times across 12 shared years of data; in 2014 it was Mexico ahead.
Mexico ranks 36th and Singapore ranks 39th of 85 countries.
Across the 2 decades both report, Mexico averaged higher in 1 and Singapore in 1.
Head to head by decade
| Decade | Mexico | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 31 | 0.6667 | 30.33 | Mexico |
| 2020s | 58.17 | 65.5 | 7.33 | Singapore |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher coverage of the human papillomavirus vaccine, Mexico or Singapore?
- Mexico, at 72 against 71 in Singapore as of 2025.
- What is the difference in coverage of the human papillomavirus vaccine between Mexico and Singapore?
- 1, with Mexico ahead.
- How many years of comparable data are there for Mexico and Singapore?
- 12 years are reported by both, from 2014 to 2025.
- How do Mexico and Singapore rank globally for coverage of the human papillomavirus vaccine?
- Mexico ranks 36th and Singapore ranks 39th of 85 countries.
- Where does this data come from?
- Our World in Data, published as Coverage of the human papillomavirus vaccine. Statizoid refreshes it automatically from the source and publishes the full history for both places.